Thursday, 21 Sep 2017

TNF inhibitor

Datesort ascending Type Title Save
15 Mar 2017 Social 1241 PsA TNFi initiations - Persistence predictors include TNFi naive, more skin, prior DMARDs, Mod/High Dz activity https://t.co/WnFj6WtS33
10 Mar 2017 Social 2015 study of 4504 IBD pts shows TNFi use has 2 fold risk of central demyelinating Dz, w/ absolute risk 3.9/10000 PY https://t.co/v0MMvasUic
09 Mar 2017 Social Analysis of FDA FAERS database shows TNF inhibitor ISRs are lower in pts >70yrs & lower when TNFi combined w/ MTX https://t.co/B4t6ivsQDG
08 Mar 2017 Social Case and Review- Etanercept and other TNFi can be safely used to treat HIV positive patients. https://t.co/Ak0YE8XuuO
04 Mar 2017 Social RT @ACRheum: #Biosimilars: What Do Patients Need to Know? Read the Q&A blog post from @AngusWorthing & @ACRSimpleTasks → https://t.co/GP9wC…
03 Mar 2017 Social RT @USBiosimilars: #AAD2017 Surveyed physicians lack understanding of interchangeability. #Biosimilars Forum has info on this concept. http…
17 Feb 2017 Social New Bluetooth device and App to monitor the temperature of your biologic therapy. KEEP IT OUT OF THE VEGGIE CRISPER https://t.co/yghCLkUFIq
17 Feb 2017 Social RT @DrRachelTate: Biosimilars - noninferior in switch trial from IFX and CT-P13 @RheumNow @RWCSmtg https://t.co/bBAaUWHGt1
15 Feb 2017 Social RT @DrRachelTate: Biosimilars - noninferior in switch trial from IFX and CT-P13 @RheumNow @RWCSmtg https://t.co/bBAaUWHGt1
03 Feb 2017 Social infliximab 4 wks before TKA or THA did not increase risk of infection https://t.co/0PPLyNnNP5 @CCalabreseDO @HealioRheum @medpagetoday
31 Jan 2017 News Is the Jury Still Out on Triple Therapy vs. MTX + TNF inhibitor?
24 Jan 2017 Social Janssen has applied to FDA for new indications (AS, PsA) for golimumab based on GO-ALIVE, GO-VIBRANT trials https://t.co/qTZMJtWmya
12 Jan 2017 Social ARTIS #RA registry shows those initiating TNFi within 3 yrs of onset, double their odds of returning to work. https://t.co/WytSlSYRj1
04 Jan 2017 Social TNF inhibitor survival in 2687 Finnish pts - 27% discontinue TNFi in 12 mos. Worse w/ CZP & Rem, better w/ combo MTX https://t.co/13vJxWGWCs
02 Jan 2017 News Cautious Optimism for Biosimilars in Rheumatology
02 Jan 2017 Social Systematic review of >1000 IBD pts Tx w/ biosimilar CT-P13 v Remicade shows no difference in efficacy, safety, ADAbs https://t.co/BElV5shX03
21 Dec 2016 Social Janssen has filed for Simponi (golimumab) approvals for psoriatic athritis and anklylosing spondylitis https://t.co/dBv1o5WupX
13 Dec 2016 News Supreme Court Declines Biosimilar Patent Dispute
12 Dec 2016 News Random Drug Levels and Anti-Drug Antibodies Predict Rheumatoid Outcomes
05 Dec 2016 News Key Lessons from the TNF Inhibitor Head-to-Head EXXELERATE Study